Skip to main content
Clinical Trials/CTRI/2021/03/031611
CTRI/2021/03/031611Not yet recruitingPhase 2

Efficacy of Majoon Mundi and Roghan Gul in Chronic Plaque Psoriasis (Taqashur-e-Jild) â?? A Randomized Controlled Clinical Trial.

ational Institute of Unani Medicine0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Patients of Chronic plaque psoriasis
  • •2. Patients of both sexes
  • •3. Patients in age group of 18-60 years

Exclusion Criteria

  • •Patients below and above the age of 18 and 60 years respectively.
  • •ï?? Pregnant and lactating mothers.
  • •ï?? Patients with previous treatment history of methotrexate or biologic TNF antagonist within 3 months of baseline.
  • •ï?? Patients with uncontrollable significant diseases like DM, renal failure, hepatic failure and cardiac comorbidities.
  • •ï?? Patients suffering from other concomitant skin diseases like Vitiligo, Eczema, Lichen Simplex & Seborrheic Dermatitis.
  • •ï?? Patients with Erythrodermic and Pustular psoriasis

Investigators

Sponsor
ational Institute of Unani Medicine

Similar Trials